These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and long-term adverse effect pattern of lovastatin. Tobert JA Am J Cardiol; 1988 Nov; 62(15):28J-34J. PubMed ID: 3055921 [TBL] [Abstract][Full Text] [Related]
3. Clinical experience with lovastatin. Tobert JA; Shear CL; Chremos AN; Mantell GE Am J Cardiol; 1990 Mar; 65(12):23F-26F. PubMed ID: 2180268 [TBL] [Abstract][Full Text] [Related]
4. Safety and compliance with once-daily niacin extended-release/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study. Rubenfire M; Am J Cardiol; 2004 Aug; 94(3):306-11. PubMed ID: 15276093 [TBL] [Abstract][Full Text] [Related]
5. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system). Alsheikh-Ali AA; Karas RH Am J Cardiol; 2007 Feb; 99(3):379-81. PubMed ID: 17261402 [TBL] [Abstract][Full Text] [Related]
6. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up. Bradford RH; Shear CL; Chremos AN; Dujovne CA; Franklin FA; Grillo RB; Higgins J; Langendorfer A; Nash DT; Pool JL Am J Cardiol; 1994 Oct; 74(7):667-73. PubMed ID: 7942524 [TBL] [Abstract][Full Text] [Related]
10. Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia. Yim BT; Chong PH Ann Pharmacother; 2003 Jan; 37(1):106-15. PubMed ID: 12503944 [TBL] [Abstract][Full Text] [Related]
11. Lovastatin/gemfibrozil myopathy: a clinical, histochemical, and ultrastructural study. Chucrallah A; De Girolami U; Freeman R; Federman M Eur Neurol; 1992; 32(5):293-6. PubMed ID: 1521554 [TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
13. The liver and lovastatin. Tolman KG Am J Cardiol; 2002 Jun; 89(12):1374-80. PubMed ID: 12062731 [TBL] [Abstract][Full Text] [Related]
14. Lovastatin extended release: a review of its use in the management of hypercholesterolaemia. Curran MP; Goa KL Drugs; 2003; 63(7):685-99. PubMed ID: 12656649 [TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Hsu I; Spinler SA; Johnson NE Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093 [TBL] [Abstract][Full Text] [Related]
16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]